These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22545041)

  • 21. Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients.
    Scarabino D; Broggio E; Gambina G; Corbo RM
    Exp Gerontol; 2017 Nov; 98():143-147. PubMed ID: 28827085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sleep spindles, K-complexes, limb movements and sleep stage proportions may be biomarkers for amnestic mild cognitive impairment and Alzheimer's disease.
    Liu S; Pan J; Tang K; Lei Q; He L; Meng Y; Cai X; Li Z
    Sleep Breath; 2020 Jun; 24(2):637-651. PubMed ID: 31786748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional alterations of myeloid cells during the course of Alzheimer's disease.
    Thome AD; Faridar A; Beers DR; Thonhoff JR; Zhao W; Wen S; Pascual B; Masdeu JC; Appel SH
    Mol Neurodegener; 2018 Nov; 13(1):61. PubMed ID: 30424785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.
    Chou YY; Leporé N; Avedissian C; Madsen SK; Parikshak N; Hua X; Shaw LM; Trojanowski JQ; Weiner MW; Toga AW; Thompson PM;
    Neuroimage; 2009 Jun; 46(2):394-410. PubMed ID: 19236926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Inflamma-miRs as Potential Biomarkers of Cognitive Impairment in Patients Affected by Alzheimer's Disease.
    Giuliani A; Gaetani S; Sorgentoni G; Agarbati S; Laggetta M; Matacchione G; Gobbi M; Rossi T; Galeazzi R; Piccinini G; Pelliccioni G; Bonfigli AR; Procopio AD; Albertini MC; Sabbatinelli J; Olivieri F; Fazioli F
    Front Aging Neurosci; 2021; 13():647015. PubMed ID: 33776746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
    Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
    Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Tau Proteins as Potential Biomarkers for the Assessment of Alzheimer's Disease Progression.
    Nam E; Lee YB; Moon C; Chang KA
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment.
    Hu WT; Chen-Plotkin A; Arnold SE; Grossman M; Clark CM; Shaw LM; Pickering E; Kuhn M; Chen Y; McCluskey L; Elman L; Karlawish J; Hurtig HI; Siderowf A; Lee VM; Soares H; Trojanowski JQ
    Acta Neuropathol; 2010 Jun; 119(6):669-78. PubMed ID: 20232070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.
    Martin E; Boucher C; Fontaine B; Delarasse C
    Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
    Goldknopf IL; Park HR; Sabbagh M
    Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impairment of Several Immune Functions and Redox State in Blood Cells of Alzheimer's Disease Patients. Relevant Role of Neutrophils in Oxidative Stress.
    Vida C; Martinez de Toda I; Garrido A; Carro E; Molina JA; De la Fuente M
    Front Immunol; 2017; 8():1974. PubMed ID: 29375582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer's disease.
    Wang J; Chen C; Zhang Y
    J Clin Lab Anal; 2020 Jan; 34(1):e23006. PubMed ID: 31420923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis.
    Struyfs H; Van Broeck B; Timmers M; Fransen E; Sleegers K; Van Broeckhoven C; De Deyn PP; Streffer JR; Mercken M; Engelborghs S
    J Alzheimers Dis; 2015; 45(3):813-22. PubMed ID: 25633670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.
    Zainal NH; Silva E; Lim LL; Kandiah N
    Ann Acad Med Singap; 2016 Jul; 45(7):273-83. PubMed ID: 27523508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of preclinical Alzheimer's disease in a clinical setting.
    Visser PJ; Verhey FR; Ponds RW; Jolles J
    Int Psychogeriatr; 2001 Dec; 13(4):411-23. PubMed ID: 12003248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive impairment and Alzheimer's disease: Links with oxidative stress and cholesterol metabolism.
    Sekler A; Jiménez JM; Rojo L; Pastene E; Fuentes P; Slachevsky A; Maccioni RB
    Neuropsychiatr Dis Treat; 2008 Aug; 4(4):715-22. PubMed ID: 19043515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
    Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
    J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiRNA -483-5p as a Potential Noninvasive Biomarker for Early Detection of Alzheimer's Disease.
    Sabry R; El Sharkawy RE; Gad NM
    Egypt J Immunol; 2020 Jun; 27(2):59-72. PubMed ID: 33548978
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.